AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease – The Manila Times

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease  The Manila Times